Clinical Trial Update: pRophylactic halopEriDol Use for Delirium in iCu patiEnts With a High Risk for Delirium [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on prophylactic haloperidol use to prevent delirium in ICU patients at high risk; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• HALOPERIDOL (HALOPERIDOL LACTATE)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Delirium | Phase 4 | Status: COMPLETED